What is the benefit of the determination of quantitative PCR for polyomavirus in renal transplant recipients? And is there any value in screening kidney donors for polyomavirus?
This consensus statement reviews the experience in the field of pediatric lung transplantation and highlights areas that deserve further investigation.
We have a 17-year-old patient with ESRD, moderate hemophilia B, and noncirrhotic hepatitis C virus infection. Should this patient be considered for kidney-liver transplantation?
Could coronary stents serve as palliative therapy for pediatric heart transplant patients with CAD? Dr. Ron Shapiro discusses a study that suggests this as a viable strategy.
Should retransplantation be considered in the patient with primary graft nonfunction after liver transplantation for acetaminophen-induced acute liver failure?
Dr. Ron Shapiro discusses the implications of a Parisian study that found sirolimus effective for the treatment of refractory graft-vs-host disease in bone marrow transplant recipients.
This study provides a rigorous comparison of steady-state pharmacokinetics of twice daily oral MMF in male and female AA and Caucasian stable renal transplant patients.